Source: Eur Respir J 2014; 44: 1366-1369
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sun Amanda Y., Denkinger Claudia M., Dowdy David W.. The impact of novel tests for tuberculosis depends on the diagnostic cascade. Eur Respir J 2014; 44: 1366-1369

Member's Comments

No comment yet.

Related content which might interest you: The role of a new immuno-diagnostic test based on ESAT-6 epitopes in the screening of subjects with a clinical suspicion of active tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 166s Year: 2003 Timing of serodiagnostic tests for tuberculosis affects sensitivity Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002 Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10 Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008 An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018 Year: 2018 Evaluation of new biomarkers for laboratory diagnosis of tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018 Year: 2018 Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents Year: 2008 Performance of five serological tests using different antigens in rapid diagnosis of tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Is PPD still a screening diagnostic tool for tuberculosis alone, or for something else also? Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006 Comparison of molecular and immunological methods for a rapid diagnosis of smear-negative tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Are in vitro sensitivity tests for tuberculosis drugs a good guide of clinical outcome? Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level Year: 2006 Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 PCR based method for accurate diagnosis of mycobacterial disease and description of clinical profile of disease caused by non tuberculous mycobacteria Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB Source: Eur Respir Mon 2012; 58: 1-13 Year: 2012 Modern molecular direct tests for rapid identification and drug susceptibility testing of Mycobacterium tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Evaluation of DestiNA ‘spin-tube’ technology – a novel test for the diagnosis of tuberculosis and mycobacteriosis Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020 The potential impact of COVID-19-related disruption on tuberculosis burden Source: Eur Respir J, 56 (2) 2001718; 10.1183/13993003.01718-2020 Year: 2020 The diagnostic efficiency of TB quantiferon gold test in tuberculosis (preeliminary reports) Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 Enhanced diagnosis of tuberculosis using a dual gene target detection approach Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method Source: Eur Respir J 2016; 48: 1160-1170 Year: 2016